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ABSTRACT
A simple real-time ﬂuorescence resonance energy transfer (FRET) PCR, targeting the gyrA gene outside
the quinolone resistance-determining region, was developed to identify Campylobacter jejuni and
Campylobacter coli. These species were distinguished easily, as the corresponding melting points showed
a difference of 15C. A second assay using the same biprobe and PCR conditions, but different PCR
primers, was also developed to identify the less frequently encountered Campylobacter fetus. These assays
were applied to 807 Campylobacter isolates from clinical specimens. Compared to phenotypic
identiﬁcation tests, the FRET assay yielded the same results for all except three of the isolates. Analysis
by standard PCR and 16S rDNA sequencing demonstrated that two of these isolates were hippurate-
negative C. jejuni strains, resulting in an erroneous phenotypic identiﬁcation, while the third was an
isolate of C. coli that contained a gyrA gene typical of C. jejuni, resulting in misidentiﬁcation by the FRET
assay. The FRET assay identiﬁed more isolates than standard PCR, which failed to yield ampliﬁcation
products with c. 10% of isolates. It was concluded that the FRET assays were rapid, reliable,
reproducible and relatively cost-efﬁcient, as they require only one biprobe and can be performed
directly on boiled isolates.
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INTRODUCTION
The incidence of Campylobacter-associated food
poisoning has gradually increased, and this
organism is now considered to be the leading
cause of bacterial gastroenteritis worldwide [1].
The species isolated most frequently from man
are Campylobacter jejuni [1], Campylobacter coli and
Campylobacter upsaliensis [2]. Another important
species is Campylobacter fetus, a common cause of
sepsis or extra-intestinal infections which, in our
experience, ranks third among the Campylobacter
spp. encountered in human disease [3]. Campylo-
bacters have a limited range of phenotypic
characteristics that can be used for species identi-
ﬁcation. While the hippurate hydrolysis test [4]
has great value in differentiating C. jejuni (posit-
ive) from C. coli (negative), this assay can be
difﬁcult to interpret, and atypical hippurate-
negative C. jejuni isolates have been reported.
Indeed, while hippurate-negative C. jejuni isolates
constitute a relatively small percentage (1.6%) of
total C. jejuni isolates, they represent 20% of all
hippurate-negative Campylobacter isolates [5]. In
addition, identiﬁcation of C. jejuni and C. coli on
the basis of nalidixic acid susceptibility is now
impracticable, given the high rate of acquired
nalidixic acid resistance in these species [6].
Moreover, the emergence of Arcobacter spp.,
which have phenotypic characteristics close to
those of C. fetus or C. coli, as human pathogens is
a further limitation to the use of conventional
phenotypic tests.
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The problems associated with the standard
phenotypic methods for identiﬁcation of Campy-
lobacter spp. have led to the development of new
molecular approaches to assist in the identiﬁca-
tion of these organisms [7]. Among these meth-
ods, real-time PCR using the ﬂuorescence
resonance energy transfer (FRET) technology is
very promising, since it can detect single nucleo-
tide polymorphisms with only one biprobe. The
present study describes the application of this
technique to the identiﬁcation of the most fre-
quent pathogenic Campylobacter spp. by targeting
the essential gyrA gene outside the quinolone
resistance-determining region.
MATERIALS AND METHODS
Bacteria
The strains used as positive controls (n = 22) were eight
C. jejuni subsp. jejuni strains (comprising strain NCTC 11168
(CIP 107370), strain CCUG 11284 and six clinical isolates:
strains 01248, 01252, 01253, 01251, 01197 and 93097), C. jejuni
subsp. doylei strain NCTC 11951 (CIP103751), eight C. coli
strains (comprising strain NCTC 11366 (CIP 7080) and seven
clinical isolates: strains 01260, 88642, 87003, 01271, 01187, 01227
and 00254), and ﬁve C. fetus strains (comprising strain NCTC
10842 (CIP 53.96) and four clinical isolates: strains 01125,
01185, 95125 and 01190).
Various bacterial species were used to investigate the
speciﬁcity of the PCR primers, including enteric bacteria such
as Escherichia coli, Salmonella Enteritidis, Salmonella Typhimu-
rium, and other species from the family Campylobacteraceae,
such as Campylobacter hyointestinalis, Campylobacter sputorum,
C. upsaliensis (all clinical isolates), Campylobacter lari (CCUG
23947) and Arcobacter butzleri (CCUG 10373). Also included
were Flexispira rappini (CCUG 29176) andHelicobacter spp. such
as Helicobacter pylori (ATCC 700392 and 700824), Helicobacter
felis (CCUG 28539 T), Helicobacter bilis (ATCC 51630), Helicob-
acter hepaticus (ATCC 51448), Helicobacter muridarum (ATCC
49282) and Helicobacter pullorum (CCUG 33842 and CCUG
33839).
In total, 807 Campylobacter isolates from clinical specimens,
mostly faeces, obtained throughout France between Novem-
ber 2003 and February 2004 and received successively at the
French National Campylobacter Reference Centre, were tested
in this study. All were identiﬁed to the genus level by
phenotypic methods, i.e., morphology, motility, growth in a
microaerobic atmosphere, and positive oxidase activity.
Identiﬁcation to the species level was achieved by phenotypic
methods [8] based on biochemical and physiological charac-
teristics (i.e., growth at 25C, catalase activity and hippurate
hydrolysis test) and susceptibility to antibiotics (nalidixic acid
and cephalothin). The ﬁrst 100 isolates were also examined
with a PCR species identiﬁcation assay for C. jejuni and
C. coli [9,10]. Sequencing of the 16S rRNA gene was used to
analyse discordant results (see below). All isolates were
stored frozen at ) 80C until required for testing, and were
then grown at 37C on trypticase soy medium (bioMe´rieux,
Marcy l’Etoile, France) containing horse blood 5% v ⁄v under
microaerobic conditions (N2 85%, O2 5%, CO2 10%, v ⁄v) for
24 h.
DNA preparation
Genomic DNA was isolated from control strains and the
bacterial species used to determine PCR speciﬁcity with a
QIAamp DNA mini kit (Qiagen SA, Courtaboeuf, France). For
the other 807 Campylobacter isolates tested in this study, the
conventional boiling method was used to prepare the DNA
template. Puriﬁed DNA was stored at ) 20C.
Identiﬁcation of Campylobacter spp. by DNA sequencing of
the 16S rRNA gene
For isolates that failed to produce an amplicon by the real-time
FRET-PCR (see below), a c. 1150-bp fragment of the 16S rRNA
gene was ampliﬁed with the pseudo-universal primers
F2-16S-CHPEC (5¢-ATCCTGGCTCAGAGTGAACG-3¢) and
R2-16S-CHPEC (5¢-AAGGGCCATGATGACTTGAC-3¢) and
sequenced on both strands. Ampliﬁed primer-less sequences
were compared to the GenBank database with the BLAST
program (http://www.ncbi.nlm.nih.gov/blast/) [11].
Primer design
All standard PCR primers used in this study were designed
using the web Primer3 software (http://www.broad.mit.
edu/cgi-bin/primer/primer3_http://www.cgi).
PCR and DNA sequencing of the gyrA gene
Apart from sequences for the quinolone resistance-determin-
ing region of several C. coli gyrA genes [12], the only complete
sequences of the gyrA gene available were those of two
C. jejuni strains (strains NCTC 11168 and UA580; GenBank
accession numbers AL139077 and L04566) and one C. fetus
strain (strain UA60; GenBank accession number U25640).
These three sequences were aligned and a search was
performed to identify conserved regions at the extremities of
the gene. Following this alignment, two sets of primers
(Table 1) were designed to amplify a 2798-bp or a 2740-bp
sequence from C. jejuni or C. fetus isolates, respectively (F3 ⁄R1-
gyrA-camp), and a c. 2390-bp sequence from C. coli isolates
(F4 ⁄R2-gyrA-camp).
The gyrA gene from 17 clinical Campylobacter control isolates
(C. jejuni strains 01248, 01252, 01253, 01251, 01197 and 93097;
C. coli strains 01260, 88642, 87003, 01271, 01187, 01227 and
00254; and C. fetus strains 01125, 01185, 95125 and 01190) was
ampliﬁed with the above primers and partially sequenced
with PCR primers and internal primers F1-, F6-, F8- and
R3-gyrA-camp (for C. jejuni and C. coli strains), and F1-, F6- and
R3-gyrA-camp (for C. fetus strains) (Table 1).
Design of primers and probes for FRET identiﬁcation of
C. jejuni, C. coli and C. fetus
The available gyrA sequences from C. jejuni and C. fetus,
together with part of the region of the newly sequenced gyrA
genes, were aligned, and a search was performed to design
probes that could differentiate between C. jejuni, C. coli and
C. fetus. LightCycler probe design software v. 1.0 (Roche
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Diagnostics, Neuilly sur Seine, France) and the LC-PDS
module with the mutation search module (Roche Applied
Science, Mannheim, Germany) were used. The sensor probe,
5¢-labelled with LC-Red 640 and 3¢-phosphorylated, hybridised
precisely with the C. coli gyrA sequence, and with three and
four nucleotide mismatches, respectively, with the C. jejuni
and C. fetus gyrA sequences (Fig. 1). The anchor probe
(Tm = 67.7C), 3¢-labelled with ﬂuorescein, hybridised ﬁve
bases upstream from the sensor probe (Tm = 61.5C), with a
frequent A ⁄G mismatch at position 1119 of the gyrA gene for
C. jejuni strains (Fig. 1), but this mismatch is in the middle of
the probe and was not predicted to result in a signiﬁcant
decrease in Tm. Oligonucleotide primers were also designed,
based on the C. coli gyrA gene, to identify C. jejuni and C. coli,
and on the C. fetus gyrA gene to identify C. fetus, according to
the same principles. Primer F3 ⁄R4-gyrA-CJ-CC was selected
to identify C. jejuni and C. coli, and primer F2 ⁄R2-gyrA-CF to
identify C. fetus (Table 1). F3-gyrA-CJ-CC presents a very rare
Table 1. Sequences of the primers
and probes designed for this study
Primer designation Sequences (5¢ to 3¢) Nucleotide positions
gyrA ampliﬁcation and sequencing
F3-gyrA-camp GYGTTATWATAGGTCGTGCTTTGC (sense) 89–112
R1-gyrA-camp AATTCCYTCRCCRACTGCTG (antisense) 231–212a
F4-gyrA-camp GAGCGTTATTATAGGTCGTG (sense) 87–112
R2-gyrA-camp CGTATTACGCCCTGCTTTTC (antisense) 2472–2453
F1-gyrA-camp GGAATATCTGAAGTAAGAGATGAGAGC (sense) 865–891
F6-gyrA-camp CAAAARGCAAGAGCAAGAGC (sense) 1114–1133
F8-gyrA-camp GGCCGTTTAACAGGACTTG (sense) 1291–1309
R3-gyrA-camp CCTTCAGGAATTTTATAAACTTTAAGC (antisense) 1730–1704
LC-FRET assays
F3-gyrA-CJ-CC GTACTTTTGGTGTGATTATG (sense) 986–1005
R4-gyrA-CJ-CC TTATCTCTTTTAATTCATCGCG (antisense) 1429–1408
F2-gyrA-CF GATGCTATGAGTGAGATCGT (sense) 934–953b
R2-gyrA-CF CAGAGTTTGTATCGGCG (antisense) 1222–1206b
Sensor Red 640-GTTCGTCTGATAATCACTGTTTTTCTATG-p (antisense) 1100–1072
Anchor GCTCTTGCTCTTGCTTTTTGAAGTTCAA-F (antisense) 1133–1106
The nucleotide positions of primers and probes were compared to the gyrA gene numeration of the Campylobacter
jejuni NCTC 11168 reference strain.
aThis nucleotide position was compared to the probable lipoprotein Cj1026c gene numeration of the NCTC 11168
reference strain.
bThese nucleotide positions were compared to the gyrA gene numeration of the Campylobacter fetus UA60 reference
strain.
Fig. 1. Internal nucleotide sequence of the gyrA gene from the three major pathogenic Campylobacter spp., showing the
location of the probes used for real-time PCR ampliﬁcation. The sequences are shown from nucleotides 1048 to 1147 as
compared to Campylobacter jejuni NCTC 11168 reference strain (GenBank accession number AL139077). The sensor probe
(boxed) is 5¢-labelled with LC-Red 640 (LightCycler-Red 640-N-hydroxysuccinimide ester), and a 3¢ terminal phosphate
block was added. The anchor probe (underlined) is 3¢-labelled with ﬂuorescein. M, mutations on the sensor probe inducing
a different melting point (when FRET was used). X, silent anchor probe mutations. *, spontaneous point mutations outside
the region of interest. The C. jejuni (strains NCTC11168 and UA580; GenBank accession numbers AL139077 and L04566)
and Campylobacter fetus (strain UA60; GenBank accession number U25640) gyrA genes are also included.
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mismatch at its 5¢-end on the C. coli sequence, and R4-gyrA-CJ-
CC presents a mismatch at its 5¢-end on the C. jejuni sequences
(data not shown). As these mismatches are localised at the
5¢-end of the primers, they should not have any inﬂuence on
the efﬁciency of the PCR.
Real-time FRET-PCR for the identiﬁcation of Campylobacter
spp. with the biprobe
The PCR and hybridisation reactions were performed in glass
capillary tubes in a LightCycler thermocycler (Roche Diagno-
stics). Each 7-lL reaction mixture contained 0.7 lL of FastStart
DNAMaster Hybridization probemixture (Roche Diagnostics),
3 mM MgCl2, 0.72 lM forward and reverse primers, 0.2 lM
each probe, and 0.7 lL of template DNA. Following initial
denaturation at 95C for 10 min with a temperature transition
rate of 20C ⁄ s, 50 ampliﬁcation cycles (95C for 6 s, 54C for 12 s
and 72C for 25 s) were performed with a temperature
transition rate of 20C ⁄ s. Fluorescence was measured at
640 nm after each cycle. This was followed by a melting
program of 95C for 60 s, 38C for 50 s at a temperature
transition rate of 20C ⁄ s, and 80C for 0 s (hold time) at a rate of
0.1C ⁄ s, with continuous monitoring of the ﬂuorescence. The
ﬁnal step consisted of cooling at 20C ⁄ s to 40Cwith a 30-s hold.
RESULTS AND DISCUSSION
Development of the assay
Three real-time detection formats are currently
available, namely SYBR Green, TaqMan and
FRET chemistries. The SYBR Green format was
excluded, since no probe is used and the specif-
icity is not optimal. In order to identify the two
Campylobacter spp. encountered most frequently,
the TaqMan chemistry would require a mixture of
at least two probes (each labelled twice), with a
cost at least double that of FRET with the single
nucleotide polymorphism detection format, for
which only one biprobe (labelled once) is used.
For this reason, FRET was chosen for develop-
ment in the present study.
The primer set and biprobe were designed to
target a gene common to Campylobacter spp., but
with species-speciﬁc sequence divergences to
allow differentiation by melting curve analysis.
Since the goal of the study was to identify all of
the C. jejuni and C. coli isolates, ribosomal genes
were not considered, as the 16S rDNA sequences
are highly conserved [13] and do not allow a clear
differentiation [14]. Other genes common to both
C. jejuni and C. coli include the ceuE gene,
encoding a lipoprotein involved in the transport
system for the siderophore enterochelin [15,16],
and the gyrA gene, encoding a subunit of DNA
gyrase [17–19], which is also an important tool for
bacterial phylogeny [20–22]. Although iron acqui-
sition is a crucial aspect of bacterial infectivity, the
ceuE gene is not essential for bacterial viability, in
contrast to the gyrA gene, which was therefore
chosen to ensure a common target for PCR
ampliﬁcation.
Alignment of the available gyrA sequences from
two isolates of C. jejuni and one of C. fetus, as well
as newly sequenced gyrA genes (c. 711 bp) from
six C. jejuni, seven C. coli, four C. fetus strains and
one C. lari strain, revealed that the C. jejuni and C.
coli gyrA genes were closely related, while the
C. lari and C. fetus gyrA genes were more distant
from each other (Fig. 2). In contrast to the recently
published dendrogram based on 16S rRNA
gene sequence similarity [13], there was a clear
distinction between the C. jejuni and C. coli strains.
Numerous nucleotide sequence variations were
observed between the C. jejuni, C. coli and C. fetus
gyrA genes. The various constraints of design
imposed by the LightCycler probe design soft-
ware (highly conserved anchor probe and mis-
matches on the sensor probe, a maximum gap of
ﬁve bases between the probes, and the need to
take into account the melting temperature of the
probes) allowed only one region of the gyrA gene
(nucleotides 1072–1136) to be used to design the
sensor and anchor probes. As C. coli is clustered
phylogenetically between C. jejuni and C. fetus
(Fig. 2), and in order to use the same biprobe for
C. jejuni, C. coli and C. fetus identiﬁcation with a
Fig. 2. Dendrogram of Campylobacter spp. based on data
from 711 bp of the gyrA gene. Most sequences grouped
into species-speciﬁc clusters. Strain sequences obtained
from GenBank are indicated by asterisks.
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minimum of mismatches between the sensor
probe and the target Campylobacter DNA, all of
the probes used in this study were designed
around the C. coli gyrA gene sequence. Primers for
the identiﬁcation of C. jejuni and C. coli targeted
the C. coli gyrA gene in a region that was highly
conserved for these two species. Primers for the
identiﬁcation of C. fetus speciﬁcally targeted
variations found in the C. fetus gyrA gene
sequence.
Identiﬁcation of control strains
Melting curve analysis of the 444-bp amplicons
from C. coli (n = 8) and C. jejuni (n = 9) control
strains indicated Tm values of c. 64.4C and
48.8C, respectively (Fig. 3), thereby allowing a
clear differentiation between these two species.
The rare C. jejuni subspecies doylei could not be
differentiated from the common C. jejuni subspe-
cies jejuni. A maximum difference of 0.2C in the
melting peak temperatures was observed between
different runs, resulting from variations in the
temperature proﬁle created by the LightCycler
instrument. Using boiled cell lysates, this real-
time PCR assay was able to detect one to seven
copies of the C. coli or C. jejuni genomes. No
ampliﬁcation occurred with the various other
bacterial species listed in Materials and Methods.
As this assay did not allow the identiﬁcation of
C. fetus, the third most frequently encountered
Campylobacter spp. in France, a second assay was
developed with the same biprobe, but with
different primers that ampliﬁed 289 bp of the
C. fetus gyrA gene, with all of the reactions being
performed under the same conditions and in the
same run. Melting curve analysis of amplicons
from C. fetus control strains (n = 5) exhibited a
very low Tm of c. 48.4C (data not shown), caused
by four nucleotide mismatches between the sen-
sor probe and the C. fetus gyrA gene (Fig. 1). This
real-time PCR assay did not amplify the gyrA
gene from Campylobacter spp. other than C. fetus,
or that from strains of the other bacterial species
tested. A difference in Tm of 0.8C was observed
for a few C. fetus strains between different
runs, although sequencing revealed an identical
sequence for these PCR products. This variation
may result from an unstable hybridisation caused
by nucleotide mismatches at the 3¢-end of the
sensor probe (Fig. 1).
The close proximity of the Tm for C. fetus
(48.4C) and that for C. jejuni (48.8C), and the fact
that a few C. fetus strains showed slight melting
peak variations between different runs, meant
that these two species could not be differentiated
simultaneously, thereby excluding the possibility
of a multiplex PCR.
Identiﬁcation of Campylobacter spp. in clinical
specimens
Among the 807 clinical isolates investigated, real-
time FRET-PCR with the appropriate primers
identiﬁed 593 (73%) C. jejuni, 151 (19%) C. coli
and 31 (4%) C. fetus, with 32 (4%) isolates failing
to produce a signal. Sequencing of the 16S rRNA
gene from the non-identiﬁed isolates yielded
16 A. butzleri strains, 11 C. lari strains, three
C. upsaliensis strains, one C. hyointestinalis strain
and one H. pullorum strain.
With three exceptions where an unexpected Tm
was obtained, there was a perfect correlation
between the 775 results obtained with the
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Fig. 3. Melting curve analysis
obtained with the real-time PCR
assay for the 444-bp amplicon of the
gyrA gene from Campylobacter coli
and Campylobacter jejuni. A melting
curve corresponding to a mixture
containing C. jejuni and C. coli is also
shown, and two melting peaks with
the corresponding Tm can be
observed. Values on the y axis rep-
resent the ratio of the ﬁrst negative
derivative of the change in ﬂuores-
cence in channel 2 (dF2) with the
variation in temperature.
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C. coli ⁄C. jejuni and C. fetus real-time PCRs and the
phenotypic methods used as a standard. Analysis
by standard PCR [9,10] and 16S rDNA sequencing
demonstrated that two of the discrepant isolates
were hippurate-negative C. jejuni strains, resulting
in an erroneous phenotypic identiﬁcation, while
the third was an isolate of C. coli that contained a
gyrA gene typical of C. jejuni, resulting in misiden-
tiﬁcation by the FRET assay. This last discrepant
result could possibly be explained by horizontal
transfer of the gyrA gene from C. jejuni to C. coli.
Hakanen et al. [23] have reported horizontal gene
transfer betweenCampylobacter spp., anddescribed
six C. jejuni strains that had replaced their gyrA
genewith a gene received fromC. coli. This transfer
involved the conserved region of the gyrA gene
associated with resistance to ﬂuoroquinolones and
resulted in antibiotic resistance. In the present
study,which concerned the conserved regionof the
gyrA gene, this event appeared to be very rare, as it
occurred only once (0.13%) among the 775 isolates
studied.
Accurate species identiﬁcation of Campylobacter
isolates is important because it is the ﬁrst step in
comparing isolates for epidemiological studies;
indeed, it is possible that outbreaks have gone
unnoticed in the past in the absence of proper
identiﬁcation of Campylobacter spp. Compared to
phenotypic tests, the assay described in the
present study has a higher speciﬁcity.
Comparison with standard multiplex PCR
Species identiﬁcation of the ﬁrst 100 C. jejuni and
C. coli isolates in the study was also performed by
standard multiplex PCR as described previously
by Stonnet et al. [9,10]. Ampliﬁcation only
occurred with 90 isolates, but there was complete
agreement between the standard multiplex and
real-time PCR methods for the 90 isolates speci-
ated. However, the real-time FRET-PCR assay
ampliﬁed more isolates than standard PCR, and
the results suggested that the boiling method,
which does not always yield PCR products by
standard PCR [24], can be applied to all isolates
when real-time FRET-PCR is used.
CONCLUSIONS
The present study developed new real-time PCRs
for the identiﬁcation of the three Campylobacter
spp. encountered most frequently. Ampliﬁcation
was always obtained, as gyrA is an essential gene.
The method was rapid, and the system of sensor
and anchor probes used in the assay was able to
discriminate between the two most common
Campylobacter spp., i.e., C. jejuni and C. coli, in a
single reaction, thereby contributing to the efﬁ-
ciency of the method. Compared to phenotypic
tests, the real-time assay had a higher speciﬁcity.
The assay was shown to be reliable, reproducible
and more sensitive than standard PCR. The assay
is relatively economical, as it can be performed
directly on boiled cell lysates with only one
biprobe in a low ﬁnal volume, and without any
need for post-PCR processing. This method can
be implemented easily in a setting where a FRET-
PCR apparatus is available. Attempts are being
made currently to extend this methodology to
other campylobacters and related bacteria.
NUCLEOTIDE SEQUENCE
ACCESSION NUMBERS
The C. jejuni, C. coli, C. fetus and C. lari partial
gyrA sequences determined in this study have
been assigned accession numbers AY575036 to
AY575041 (strains 01248, 01252, 01253, 01251,
01197 and 93097), AY575042 to AY575048 (strains
01260, 88642, 87003, 01271, 01187, 01227 and
00254), AY575049 to AY575052 (strains 01125,
01185, 95125 and 01190) and AY575053 (strain
98010), respectively.
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